BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23254732)

  • 21. Dexamethasone cyclophosphamide pulse therapy in lichen amyloidosus: a case report.
    Gupta R; Gupta S
    J Dermatolog Treat; 2007; 18(4):249-51. PubMed ID: 17671886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dexamethasone-cyclophosphamide pulse therapy in bullous autoimmune dermatoses].
    Appelhans M; Bonsmann G; Orge C; Bröcker EB
    Hautarzt; 1993 Mar; 44(3):143-7. PubMed ID: 8463094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dexamethasone-cyclophosphamide pulse therapy for pemphigus.
    Pasricha JS; Khaitan BK; Raman RS; Chandra M
    Int J Dermatol; 1995 Dec; 34(12):875-82. PubMed ID: 8647673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Weekly cyclophosphamide pulse therapy combined with corticosteroids in the treatment of pemphigus].
    Jia GQ; Chen ZQ; Li HL; Cui PG; Xu WY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Apr; 23(2):173-5. PubMed ID: 12905897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermittent high-dose dexamethasone-cyclophosphamide therapy for pemphigus.
    Pasricha JS; Thanzama J; Khan UK
    Br J Dermatol; 1988 Jul; 119(1):73-7. PubMed ID: 3408666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of pemphigus vulgaris with pulse intravenous cyclophosphamide.
    Pandya AG; Sontheimer RD
    Arch Dermatol; 1992 Dec; 128(12):1626-30. PubMed ID: 1456758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study.
    Rose E; Wever S; Zilliken D; Linse R; Haustein UF; Bröcker EB
    J Dtsch Dermatol Ges; 2005 Mar; 3(3):200-6. PubMed ID: 16372814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunopathologic features of pemphigus in the east Mediterranean region of Turkey: a prospective study.
    Akman A; Uzun S; Alpsoy E
    Skinmed; 2010; 8(1):12-6. PubMed ID: 20839419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular effects of corticosteroid pulse therapy: a prospective controlled study on pemphigus patients.
    Jain R; Bali H; Sharma VK; Kumar B
    Int J Dermatol; 2005 Apr; 44(4):285-8. PubMed ID: 15811078
    [No Abstract]   [Full Text] [Related]  

  • 32. Pituitary-adrenal function following dexamethasone-cyclophosphamide pulse therapy for pemphigus.
    Kumrah L; Ramam M; Shah P; Pandey RM; Pasricha JS
    Br J Dermatol; 2001 Dec; 145(6):944-8. PubMed ID: 11899148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of pulse-therapy on natural anticoagulant system of the endothelium in nonspecific aortoarteritis].
    Gur'eva MS; Baranov AA; Bagrakova SV; Nasonov EL; Zharikova DG
    Ter Arkh; 2003; 75(5):52-6. PubMed ID: 12847899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulse therapy in pemphigus: report of 11 cases.
    Fernandes NC; Menezes M
    An Bras Dermatol; 2013; 88(4):672-5. PubMed ID: 24068153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.
    Harper L; Morgan MD; Walsh M; Hoglund P; Westman K; Flossmann O; Tesar V; Vanhille P; de Groot K; Luqmani R; Flores-Suarez LF; Watts R; Pusey C; Bruchfeld A; Rasmussen N; Blockmans D; Savage CO; Jayne D;
    Ann Rheum Dis; 2012 Jun; 71(6):955-60. PubMed ID: 22128076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of pulse therapy in 74 patients with pemphigus.
    Roga G; Augustine M
    Indian J Dermatol Venereol Leprol; 2018; 84(3):331-333. PubMed ID: 29600798
    [No Abstract]   [Full Text] [Related]  

  • 37. Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus.
    Saha M; Powell AM; Bhogal B; Black MM; Groves RW
    Br J Dermatol; 2010 Apr; 162(4):790-7. PubMed ID: 19922532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexamethasone-cyclophosphamide pulse therapy in pemphigus.
    Kaur S; Kanwar AJ
    Int J Dermatol; 1990 Jun; 29(5):371-4. PubMed ID: 2361797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris.
    Euler HH; Löffler H; Christophers E
    Arch Dermatol; 1987 Sep; 123(9):1205-10. PubMed ID: 3632005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
    Werth VP
    Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.